434 related articles for article (PubMed ID: 16868441)
1. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
Lawn SD; Myer L; Bekker LG; Wood R
AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
[TBL] [Abstract][Full Text] [Related]
2. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
4. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
5. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
Van Rie A; Westreich D; Sanne I
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
[TBL] [Abstract][Full Text] [Related]
8. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
Bachmann MO; Timmerman V; Fairall LR
AIDS; 2015 Nov; 29(17):2261-8. PubMed ID: 26544699
[TBL] [Abstract][Full Text] [Related]
10. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.
Lawn SD; Myer L; Bekker LG; Wood R
BMC Infect Dis; 2006 Mar; 6():59. PubMed ID: 16551345
[TBL] [Abstract][Full Text] [Related]
11. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
[TBL] [Abstract][Full Text] [Related]
12. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV.
Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA
J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.
Lawn SD; Myer L; Bekker LG; Wood R
AIDS; 2007 Jan; 21(3):335-41. PubMed ID: 17255740
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.
Choun K; Thai S; Pe R; Lorent N; Lynen L; van Griensven J
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):235-42. PubMed ID: 23324313
[TBL] [Abstract][Full Text] [Related]
17. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
19. The tuberculosis challenge in a rural South African HIV programme.
Houlihan CF; Mutevedzi PC; Lessells RJ; Cooke GS; Tanser FC; Newell ML
BMC Infect Dis; 2010 Feb; 10():23. PubMed ID: 20146818
[TBL] [Abstract][Full Text] [Related]
20. The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.
Kufa T; Chihota V; Mngomezulu V; Charalambous S; Verver S; Churchyard G; Borgdorff M
BMC Infect Dis; 2016 Jun; 16():266. PubMed ID: 27286814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
